Prosperity Financial Group, Inc. Sellas Life Sciences Group, Inc. Call Options Transaction History
Prosperity Financial Group, Inc.
- $201 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
37Shares Held
6.49MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.87 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.49 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$916,9320.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$606,6460.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$537,9600.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $25.7M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...